Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss

Completed · Not applicable

Conditions studied: Major Depressive Disorder, Miscarriage, Stillbirth, Neonatal Death

In brief

The purpose of this study is to conduct a randomized pilot trial in a sample of 60 women who meet criteria for Major Depressive Disorder (MDD) 1-18 months after a perinatal loss to demonstrate the feasibility of the proposed recruitment methods and research design, of the therapist training methods, and of delivering the adapted Interpersonal Psychotherapy group treatment. The investigators would like to examine preliminary evidence for the following hypotheses: * Perinatal-loss specific IPT-G will be more acceptable to women who experience MDD following perinatal loss than will Coping with Depression (CWD). * Perinatal-loss specific IPT-G will result in reduced time to remission from MDD and reduced depressive symptoms relative to CWD. * Perinatal-loss specific IPT-G will result in increased social support and social functioning, reduced couple distress, and reduced grief relative to CWD.

Key facts

Study ID

NCT01867749

Run by

Brown University

People needed

62

Starts

2010-06-01

Expected to finish

2014-06-01

Last updated by the study team

2016-01-13

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Current Major Depressive episode.
• Experience perinatal loss 1-18 months prior to intake (including early and late fetal death and the death of a live born neonate within the first 28 days).

You may not qualify if…

• Untreated thyroid difficulties (TSH levels out of the normal range).
• Anemia (hemoglobin or hematocrit out of the normal range).
• Onset of current major depressive episode prior to news of difficulties with the pregnancy or health risk to the infant (women with prior episodes will be included).
• Current or past diagnosis of bipolar I disorder, schizophrenia or other psychotic disorder.
• Primary diagnosis of substance dependence or eating disorder.
• Acute suicidal or homicidal risk.
• Non-stable course of antidepressant medication or psychotherapy (i.e., beginning or changing dose of either within the previous 8 weeks).
• Any IPT or cognitive-behavioral treatment in the previous 8 weeks.

Where it is running

• Brown University — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.